ATRC 501
Alternative Names: ATRC-501; MAM-01; MAM01/ATRC-501Latest Information Update: 17 May 2024
At a glance
- Originator Atreca
- Class Antimalarials; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Malaria